Form 8.3: SPI LN

Summary by AI BETAClose X

Syquant Capital disclosed a 1.78% economic position in Spire Healthcare via 7,207,000 derivative reference securities as at 2 November 2026 and reported reducing long CFD exposure by 436,585 reference securities (435,869 and 716) at prices of 248.5 GBp and 248.575 GBp per share; the Form 8.3 filing states no indemnities, option arrangements or supplemental open-position attachment. The disclosed 1.78% derivative stake combined with the recent reduction of long exposure may create modest selling pressure or attract market attention and could be material to share-price moves.

Disclaimer*

UK 100

Latest directors dealings